Search results
Oppenheimer Says Biotech Stocks Look a Bit Brighter Right Now; Here Are 2 Names to Consider
TipRanks via Yahoo Finance· 2 years agoThe biotech sector, like most sections of the market, took a sound beating in the year’s first half....
Oppenheimer Sees Over 50% Gains in These 2 Stocks — Here’s Why They Could Soar
TipRanks via Yahoo Finance· 1 year agoThe shortened week kicked off with one big crisis averted for now. During the long weekend, an...
Obesity Drugs Have Multi-Billion-Dollar Market Potential, Says Oppenheimer — Here Are 2 Stocks to...
TipRanks via Yahoo Finance· 6 months agoA key to success in the stock market is a touch of foresight. Not quite precognition, but an ability...
Viking Therapeutics Stock Has 72% Upside, According to 1 Wall Street Analyst
Motley Fool via Yahoo Finance· 3 months agoInvestors looking for stocks that can make dramatic gains in a short time frame might want to turn...
Oppenheimer Predicts up to 140% Rally for These 3 Stocks — Here’s Why They Have Solid Upside
TipRanks via Yahoo Finance· 11 months agoThe summer is now upon us and it’s sunny days for the markets too. June represented the best month...
Oppenheimer Says There’s Room for up to 518% Gains in These 3 Under-the-Radar Stocks
TipRanks via Yahoo Finance· 4 months agoOptimism in the air. The S&P 500 is up 4% so far this year, and the Q4 earnings results – we’re...
‘Who Doesn’t Like a Bargain?’: Oppenheimer Suggests 2 Stocks to Buy
TipRanks via Yahoo Finance· 2 years agoThis year we saw declines pretty much across the board, with the S&P 500 tumbling ~20%. But last...
Why Viking Therapeutics Stock Was Rocketing Higher This Week
Motley Fool via Yahoo Finance· 3 months agoInvestors are very eager to buy into biotechs and pharmaceuticals that are involved in developing...
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
Motley Fool via Yahoo Finance· 1 month agoCRISPR Therapeutics (NASDAQ: CRSP) closed last week down 8.5% after reporting first-quarter...
Q4 2023 Enanta Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 7 months agoParticipants Jennifer Viera; Senior Director IR & Corporate Communications; Enanta Pharmaceuticals, Inc. Jay Luly; President, CEO, & Director; Enanta Pharmaceuticals, Inc. Paul Mellett; SVP, ...
